Delivery Order SPE2DB24D2100-SPE2DB24FBDPF

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Doxepin Hydrochloride 3 mg tablets, with a ceiling value of $4,129.19 and a period of performance through January 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Doxepin HCL 3 MG Tablets in packages of 30. The $1,795.44 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies for military treatment programs and facilities....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Doxepin Hydrochloride 3 mg tablets. The contract has a ceiling value of $2,744.99 and an ultimate completion date of November 28, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The $1,946.18 firm fixed price delivery order is for the supply of 4,564,260 units of Doxepin HCL 3 mg tablets. This delivery order supports military treatment programs and facilities, and was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568603966 - Doxepin HCL 3 MG Tablet 30S, with a ceiling value of $1,038.16. The contract is a firm fixed-price delivery order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $6,829.72 order is for the supply of 3 mg doxepin hydrochloride tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,336.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,296,828 units of Doxepin HCL 3 mg tablets. This fixed-price delivery order has an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $12,520.40 firm fixed-price contract is for the provision of Doxepin HCl 6 mg tablets and has a performance period through February 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract is for the delivery of 4564074174 - Doxepin HCL 3 MG Tablet 30S, a pharmaceutical product, with a ceiling value of $1,494.70 and a period of performance through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDPF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,804,947 units of Doxepin HCL 3 mg tablets in packages of 30. The contract has a firm fixed price of $3,555.99 and a period of performance ending on September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This contract award does not utilize a set-aside designation.

Generated 12/13/24, 9:11 AM